跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
JANSSEN ABIRATERONE abiraterone acetate 250 mg tablet bottle
Approved
STANDARD
JANSSEN ABIRATERONE abiraterone acetate 250 mg tablet bottle
Janssen-Cilag Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
55d4051e6d43106a
Company
Janssen-Cilag Pty Ltd
Type
Standard
Approval Details
Approval Id
55d4051e6d43106a
Product Name
JANSSEN ABIRATERONE abiraterone acetate 250 mg tablet bottle
Artg Id
180340
Artg Name
JANSSEN ABIRATERONE abiraterone acetate 250 mg tablet bottle
Sponsor
Janssen-Cilag Pty Ltd
Company Detail Path
/organization/janssen-cilag-pty-ltd
Artg Date
2012-03-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
55d4051e6d43106a
Type
Standard
Back to TGA Approvals
JANSSEN ABIRATERONE abiraterone acetate 250 mg tablet bottle - TGA Drug Approval Details
